Concepedia

Stephen E. Gitelman

SE

Statistics

Publications

93

Citations

15.1K

H-Index

56

Active since

1980

Affiliations

University of California, San Francisco(Current)

Yale University

Indiana University – Purdue University Indianapolis

University of South Florida

University of Florida

Stephen E. Gitelman is an author at University of California, San Francisco specializing in diabetes mellitus, endocrinology, and medicine.

ORCID

Publications per year

1980–2025

93

Publications

93

Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus

Kevan C. Herold, William Hagopian, Julie Auger et al. · New England Journal of Medicine · 2002 · 1.2K citations · Full text

, , +14

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Kevan C. Herold, Brian N. Bundy, S. Alice Long et al. · New England Journal of Medicine · 2019 · 1.1K citations · Full text

, , +17

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

Mark D. Pescovitz, Carla J. Greenbaum, Heidi Krause‐Steinrauf et al. · New England Journal of Medicine · 2009 · 1.1K citations · Full text

, , +16

Type 1 diabetes immunotherapy using polyclonal regulatory T cells

Jeffrey A. Bluestone, Jane H. Buckner, Mark Fitch et al. · Science Translational Medicine · 2015 · 1K citations

, , +11

A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes

Kevan C. Herold, Stephen E. Gitelman, Umesh Masharani et al. · Diabetes · 2005 · 636 citations · Full text

, , +16

1–5 of 93